Kendalle Burlin O’Connell

Opinion author

Kendalle Burlin O’Connell, Esq., is CEO and president of MassBio. The organization is the driving force behind the Massachusetts life sciences ecosystem, supporting innovation and industry growth by offering best-in-class resources to over 1,700 member organizations at all stages of the biopharma lifecycle.

China USA Trade War Risk and Beijing Washington Crisis as Chinese and American retaliatory tariffs as a Financial risk and investment danger as stock market turbulence as a paper boat representing global exports and imports challenges.

Opinion

The FDA must put biotech at its center or continue to cede early research to China

Last month, the FDA launched TrialBlazer, intended to streamline the IND path and bring early clinical trials and medical innovation home to the U.S. It’s a start, but new agency leadership must see it through.

July 6, 2026

4 min read

Kendalle Burlin O’Connell